These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17176317)

  • 21. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
    Diedrich B; Remberger M; Shanwell A; Svahn BM; Ringdén O
    Transfusion; 2005 Jul; 45(7):1064-72. PubMed ID: 15987349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The London Cord Blood Bank: analysis of banking and transplantation outcome.
    Davey S; Armitage S; Rocha V; Garnier F; Brown J; Brown CJ; Warwick R; Fehily D; Watt S; Gluckman E; Vora A; Contreras M; Navarrete CV
    Br J Haematol; 2004 May; 125(3):358-65. PubMed ID: 15086417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants.
    Page KM; Zhang L; Mendizabal A; Wease S; Carter S; Gentry T; Balber AE; Kurtzberg J
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1362-74. PubMed ID: 21277377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
    Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
    Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
    Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.
    Ooi J; Takahashi S; Tomonari A; Tsukada N; Konuma T; Kato S; Kasahara S; Sato A; Monma F; Nagamura F; Iseki T; Tojo A; Asano S
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1341-7. PubMed ID: 19041055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency.
    Bhattacharya A; Slatter MA; Chapman CE; Barge D; Jackson A; Flood TJ; Abinun M; Cant AJ; Gennery AR
    Bone Marrow Transplant; 2005 Aug; 36(4):295-9. PubMed ID: 15968287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma-depleted or -reduced cord blood.
    Petz L; Jaing TH; Rosenthal J; Karanes C; Nademanee A; Chan LL; Graham ML; Lin HP; Tan P; Wang BC; Fu C; Chow M; Forman S; Chow R
    Transfusion; 2012 Jun; 52(6):1311-20. PubMed ID: 22098396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age.
    Konuma T; Takahashi S; Ooi J; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Kasahara S; Nagamura-Inoue T; Uchimaru K; Iseki T; Tojo A; Yamaguchi T; Asano S
    Ann Hematol; 2009 Jun; 88(6):581-8. PubMed ID: 19030858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced.
    Chow R; Nademanee A; Rosenthal J; Karanes C; Jaing TH; Graham ML; Tsukahara E; Wang B; Gjertson D; Tan P; Forman S; Petz LD
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1346-57. PubMed ID: 17950921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
    Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results.
    Rubinstein P; Stevens CE
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):565-84. PubMed ID: 11102277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor.
    Bautista G; Cabrera JR; Regidor C; Forés R; García-Marco JA; Ojeda E; Sanjuán I; Ruiz E; Krsnik I; Navarro B; Gil S; Magro E; de Laiglesia A; Gonzalo-Daganzo R; Martín-Donaire T; Rico M; Millán I; Fernández MN
    Bone Marrow Transplant; 2009 Mar; 43(5):365-73. PubMed ID: 18850019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unrelated cord blood transplantation in children--a 10-year experience from UMMC.
    Chan LL; Lin HP; Chong LA; Hany A; Ariffin AW
    Med J Malaysia; 2009 Jun; 64(2):124-9. PubMed ID: 20058571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
    Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early identification and management of graft failure after unrelated cord blood transplantation.
    Chan KW; Grimley MS; Taylor C; Wall DA
    Bone Marrow Transplant; 2008 Jul; 42(1):35-41. PubMed ID: 18332909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.